Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Inizio leaders featured in Forbes’ ‘Voices of Oncology’ to drive innovation in cancer care

    September 24, 2025 |  

    Inizio experts contribute to Forbes’ Voices of Oncology, highlighting our commitment to driving innovation in cancer care through advanced data analytics, cross-sector collaboration, and real-world impact for patients.

    Voices-of-Oncology-Inizio

    With over 30 years of deep-rooted expertise in oncology, we partner with our clients at each pivotal moment in their journey, unlocking value through a connected suite of capabilities. Today, we’re proud to announce that a number of our leaders in Inizio have been featured in Forbes’ Voices of Oncology, a collaboration that reflects our commitment to advancing cancer care.

    Launching September 9, the ‘Voice of Innovation Partners’ chapter in Forbes’ ‘Voices of Oncology’ features contributions from:

    Accelerating innovation in oncology through collaboration, data & technology

    The ‘Voice of Innovation Partners’ chapter explores how innovation partners like Inizio harness advanced data analytics, cutting-edge technology, and cross-sector collaboration to:

    • Simplify complex challenges in oncology
    • Enhance decision-making across the cancer care continuum
    • Improve patient outcomes through real-world impact

    The book is a powerful collection of insights from global experts and thought leaders, offering a shared perspective on how we can work better together to shape the future of oncology. Voices of Oncology is an initiative of the Oncology Voice Network (OVN), a new platform built to spark connection, share knowledge, and amplify solutions across pharma, biotech, academia, and patient advocacy.

    Pre-order now: Forbes’ Voices of Oncology

    Available to pre-order now via Amazon – explore the Voices of Oncology here. If you’re looking for a partner who can turn knowledge into action and accelerate the journey from breakthrough science to real-world impact, learn more about us.

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Infographic: Therapy Watch Acute Myeloid Leukemia market snapshot

    This Acute Myeloid Leukemia infographic offers a snapshot of the real-world patient insights collected by our Therapy Watch study, based on data collected from a panel of 220 physicians across...

    Navigating the future of AI: Insights from EphMRA’s one day meeting in London

    Authored by: Ellie Forde and Mark Braund, Directors

    Research conducted for Johnson and Johnson published in scientific journal

    Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.

    Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance

    The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were impacted so they could address...

    Autoimmune conditions: Living With syndicated patient reports

    The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective management and care. In our...

    How we elevated HCP market research engagement and insights using AI avatars for an immersive experience

    Our client required an effective strategy for promoting discussions about self-paid vaccines with healthcare professionals (HCPs) during patient consultations. The conventional method of conducting market research would typically only deliver...

    How we provided comprehensive real-world patient data for PAH using Therapy Watch, our syndicated market tracking solution

    PAH is a specific type of pulmonary hypertension, which is a rare condition treated primarily in specialized centers. Our client needed to gain a comprehensive understanding of PAH patients, such...

    The risk of replicating social bias in synthetic patient data – The need for human intelligence partnered with AI

    Authored by Paul Reed and Anabelle Gall

    Latest European developments and new talent at Research Partnership

    Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...

    New syndicated report – Living with Ulcerative Colitis 2024

    Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...